AMAM vs. PFE
Compare and contrast key facts about Ambrx Biopharma Inc. (AMAM) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMAM or PFE.
Key characteristics
| AMAM | PFE |
|---|
Fundamentals
| AMAM | PFE | |
|---|---|---|
| Market Cap | $1.77B | $143.83B |
| EPS | $0.42 | $0.37 |
| PE Ratio | 66.67 | 68.65 |
| Revenue (TTM) | $4.09M | $58.50B |
| Gross Profit (TTM) | $7.40M | $66.23B |
| EBITDA (TTM) | -$61.75M | $11.52B |
Correlation
The correlation between AMAM and PFE is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMAM vs. PFE - Performance Comparison
The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMAM vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ambrx Biopharma Inc. (AMAM) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMAM vs. PFE - Dividend Comparison
AMAM has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.50%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMAM Ambrx Biopharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.50% | 5.70% | 3.12% | 2.64% | 3.71% | 3.49% | 2.96% | 3.35% | 3.51% | 3.29% | 3.17% | 2.97% |
Drawdowns
AMAM vs. PFE - Drawdown Comparison
Volatility
AMAM vs. PFE - Volatility Comparison
The current volatility for Ambrx Biopharma Inc. (AMAM) is 0.00%, while Pfizer Inc. (PFE) has a volatility of 5.96%. This indicates that AMAM experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMAM vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Ambrx Biopharma Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities